UKALL 2003 (Version 7, August 2009)
(Some of the following links are to PDF files. They can be read using the Adobe Acrobat Reader, which can be downloaded from Adobe)
N.B. Archived versions of UK ALL2003 documents can still be accessed.
UKALL2003 closed on 30 June 2011
Recruitment to UKALL 2003 closed on 30/06/2011 although the trial will remain open to follow-up for 3 years from that date. The amendment includes changes to the IMP status of 10 mg 6 MP tablets and MTX suspension as described in the application form.
Covering letter to MREC (pdf)
MREC approval (pdf)
Covering letter to MHRA (pdf)
MHRA approval (pdf)
INTERIM GUIDELINES (pdf) - amended to include updated Down's syndrome treatment recommendations
December 2010
- UKALL 2003 extended to June 2011
For MREC acknowledgement letter please click here
April 2010
UKALL 2003 extended until 30 November 2010
For MREC approval, please click here
Revised recommendation for transplantation in patients with iAMP21
For details of the above changes, please click here
Protocol
Notification of Release of UKALL2003 Protocol Version 7 (PDF)
Protocol (Version 7) (PDF)
Summary of changes (PDF)
MREC/MHRA
MREC Approval (PDF)
MHRA Approval (PDF)
Patient Information & Consent Forms
Serious Adverse Event Reporting
SAE reporting (PDF)
Forms
Trial Forms (new page)
Flow Charts
Newsletters
Newsletter April 2007 (PDF)
Annual Reports
Annual Report 2009 (PDF)
Annual Report 2008 (PDF)
Annual Report 2007 (PDF)
Annual Report 2006 (PDF)
Annual Safety Report - Please contact CTSU if you would like a copy (tel: 01865-765615, or email randomisation@ctsu.ox.ac.uk)
New Centres
Sponsor
Note: the web page http://www.cancerhelp.org.uk/trials/trials/default.asp contains some very useful information for parents about the trial. Select "children's" or "children's - leukaemia and lymphoma" from the drop down menu on the search engine.
Back to projects page
